Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)

Summary

The goal of this clinical research study is to learn if the combination of azacitidine and GM-CSF can help to control MDS. The safety of these drugs will also be studied. Azacitidine is designed to block certain proteins that stop the function of tumor-fighting genes. By blocking the "bad" proteins, the tumor-fighting genes may be able to work better. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is designed to help produce white blood cells. This may help to fight infections.

Timeline

Start

2012-03

Primary completion

2013-04

Completion

2013-04

Outcome

Outcome not reported

Stopped (Enrollment): “Slow Accrual”

Drugs

Indications